MET and glioblastoma: We employed the MTT assay in order to investigate the antiproliferative effects of the synthetic compounds against four different cancer cell lines, including lung cancer cell lines EBC-1 (with MET amplification) and A549, the human colorectal cancer cells HT-29, as well as the human glioblastoma cell line U-87MG.